NO20030296L - Heparinavledede polysakkaridblandinger, deres fremstilling samt farmasöytiske preparater inneholdende blandingene - Google Patents

Heparinavledede polysakkaridblandinger, deres fremstilling samt farmasöytiske preparater inneholdende blandingene

Info

Publication number
NO20030296L
NO20030296L NO20030296A NO20030296A NO20030296L NO 20030296 L NO20030296 L NO 20030296L NO 20030296 A NO20030296 A NO 20030296A NO 20030296 A NO20030296 A NO 20030296A NO 20030296 L NO20030296 L NO 20030296L
Authority
NO
Norway
Prior art keywords
heparin
preparation
derived polysaccharide
compositions
pharmaceutical compositions
Prior art date
Application number
NO20030296A
Other languages
English (en)
Other versions
NO20030296D0 (no
Inventor
Jacques Diaz
Christelle Pecquet
Elisabeth Perrin
Christian Viskov
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8852768&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20030296(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of NO20030296L publication Critical patent/NO20030296L/no
Publication of NO20030296D0 publication Critical patent/NO20030296D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0078—Degradation products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
NO20030296A 2000-07-21 2003-01-20 Heparinavledede polysakkaridblandinger, deres fremstilling samt farmasöytiske preparater inneholdende blandingene NO20030296D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0009572A FR2811992B1 (fr) 2000-07-21 2000-07-21 Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
PCT/FR2001/002332 WO2002008295A1 (fr) 2000-07-21 2001-07-18 Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant

Publications (2)

Publication Number Publication Date
NO20030296L true NO20030296L (no) 2003-01-20
NO20030296D0 NO20030296D0 (no) 2003-01-20

Family

ID=8852768

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030296A NO20030296D0 (no) 2000-07-21 2003-01-20 Heparinavledede polysakkaridblandinger, deres fremstilling samt farmasöytiske preparater inneholdende blandingene

Country Status (36)

Country Link
EP (1) EP1307491B2 (no)
JP (1) JP5279160B2 (no)
KR (1) KR100853585B1 (no)
CN (1) CN1230449C (no)
AP (1) AP1703A (no)
AR (1) AR029865A1 (no)
AT (1) ATE470679T1 (no)
AU (2) AU2001277602B2 (no)
BR (1) BR0112612B1 (no)
CA (1) CA2416673C (no)
CL (1) CL2004001154A1 (no)
CY (1) CY1110774T1 (no)
DE (1) DE60142340D1 (no)
DK (1) DK1307491T3 (no)
DZ (1) DZ3411A1 (no)
EA (1) EA005995B1 (no)
EC (1) ECSP034442A (no)
ES (1) ES2347134T5 (no)
FR (1) FR2811992B1 (no)
HK (1) HK1059273A1 (no)
HR (1) HRP20030019A2 (no)
HU (1) HUP0300755A3 (no)
IL (2) IL153922A0 (no)
MA (1) MA26928A1 (no)
MX (1) MXPA03000579A (no)
NO (1) NO20030296D0 (no)
NZ (1) NZ524028A (no)
OA (1) OA12340A (no)
PL (1) PL202471B1 (no)
PT (1) PT1307491E (no)
SI (1) SI1307491T1 (no)
TW (1) TWI307278B (no)
UA (1) UA74836C2 (no)
WO (1) WO2002008295A1 (no)
YU (1) YU2903A (no)
ZA (1) ZA200300898B (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6969705B2 (en) 2000-07-21 2005-11-29 Aventis Pharma S.A. Compositions of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
EP1375524B1 (en) * 2002-06-20 2007-03-07 CHEMI S.p.A. Process for the preparation of esters of heparin
AR041555A1 (es) 2002-10-10 2005-05-18 Aventis Pharma Sa Mezclas de polisacaridos derivados de heparina, su preparacion y las composiciones farmaceuticas que las contienen
US20040171819A1 (en) 2002-10-10 2004-09-02 Aventis Pharma S.A. Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
FR2845686B1 (fr) * 2002-10-10 2013-08-30 Aventis Pharma Sa Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
FR2857971B1 (fr) * 2003-07-24 2005-08-26 Aventis Pharma Sa Melanges d'oligosaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
US7956046B2 (en) * 2003-07-24 2011-06-07 Aventis Pharma S.A. Oligosaccharide mixtures derived from heparin, preparation thereof and pharmaceutical compositions containing them
DE102004059134B4 (de) 2004-12-08 2011-12-15 Siemens Ag Expansionsvorrichtung für ein Röntgengerät und Röntgenstrahler
EP2447285A3 (en) * 2006-05-25 2013-01-16 Momenta Pharmaceuticals, Inc. Low molecular weight heparin composition and uses thereof
CN101824099B (zh) * 2010-02-12 2011-11-30 淮安麦德森化学有限公司 一种粗品肝素钠的纯化方法
CN101824446B (zh) * 2010-02-24 2012-12-12 淮安麦德森化学有限公司 反向沉淀生产硫酸软骨素的方法
EP2399592A1 (en) 2010-06-25 2011-12-28 Aventis Pharma S.A. Semuloparin for use as an antithrombotic treatment in hip replacement surgery with improved safety in terms of clinically relevant bleedings and major bleedings
EP2399590A1 (en) 2010-06-25 2011-12-28 Aventis Pharma S.A. Semuloparin for the prevention of a mortality and/or morbidity event in a patient undergoing major orthopaedic surgery
EP2399591A1 (en) 2010-06-25 2011-12-28 Aventis Pharma S.A. Semuloparin for the extended prevention of a mortality and/or morbidity event in a patient having undergone hip fracture surgery
EP2399593A1 (en) 2010-06-28 2011-12-28 Aventis Pharma S.A. Semuloparin for use as an antithrombotic treatment in orthopaedic surgery with improved benefit-risk profile
CN102399379B (zh) * 2010-09-09 2016-08-31 上海喜恩医药科技发展有限公司 一种肝素衍生的多糖混合物及其制备方法和药物组合物
CA2811186C (en) * 2010-09-14 2018-12-04 Michio Muguruma High purity heparin and production method therefor
WO2012055843A1 (en) 2010-10-28 2012-05-03 Aventis Pharma S.A. Semuloparin for the prevention of major venous thromboembolism in a patient undergoing major abdominal surgery
EP2446891A1 (en) 2010-10-28 2012-05-02 Aventis Pharma S.A. Semuloparin for use as an antithrombotic treatment in major abdominal surgery with improved safety in terms of clinically relevant bleedings and major bleedings
EP2548561A1 (en) 2011-07-22 2013-01-23 Aventis Pharma S.A. Semuloparin for improving the survival of patients with locally advanced cancer
ES2445494B1 (es) * 2012-08-02 2015-03-06 Rovi Lab Farmaceut Sa Procedimiento de obtención de heparinas de bajo y muy bajo peso molecular
CN103175925B (zh) * 2013-03-20 2014-12-03 山东辰中生物制药有限公司 依诺肝素钠生产过程中肝素苄基酯的酯化率的检测方法
FR3016632A1 (fr) * 2014-01-21 2015-07-24 IFP Energies Nouvelles Procede de transformation de polysaccharides en molecules oxygenees en presence de superbases organiques neutres
CZ306662B6 (cs) * 2015-06-26 2017-04-26 Contipro A.S. Deriváty sulfatovaných polysacharidů, způsob jejich přípravy, způsob jejich modifikace a použití

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2478646A2 (fr) * 1980-03-20 1981-09-25 Choay Sa Composition mucopolysaccharidique ayant une activite regulatrice de la coagulation, medicament la contenant et procede pour l'obtenir
IL61201A (en) * 1979-10-05 1984-09-30 Choay Sa Oligosaccharides having no more than 8 saccharide moieties,their obtention from heparin and pharmaceutical compositions containing them
FR2482611B1 (fr) * 1980-05-14 1986-03-07 Pharmindustrie Nouveaux polysaccharides sulfates, procedes pour leur preparation et leur utilisation comme medicaments
US4916219A (en) * 1985-03-28 1990-04-10 University Of Iowa Research Foundation Oligosaccharide heparin fragments as inhibitors of complement cascade
EP0337327A1 (en) * 1988-04-09 1989-10-18 Bioiberica, S.A. Process for the preparation of new oligosaccharide fractions by controlled chemical depolimerization of heparin
ES2077533B1 (es) * 1994-02-28 1996-07-01 Bioiberica Procedimiento de obtencion de fracciones de oligosacaridos por despolimerizacion quimica de heparina.
JP4897991B2 (ja) * 1999-07-23 2012-03-14 ラボラトリオス ファルマセウティコス ロビ ソシエダッド アノニマ 超低分子量ヘパリン組成物
ES2161615B1 (es) 1999-07-23 2003-03-16 Rovi Lab Farmaceut Sa Composiciones de heparinas de muy bajo peso molecular.

Also Published As

Publication number Publication date
HK1059273A1 (en) 2004-06-25
CA2416673C (fr) 2011-06-14
IL153922A (en) 2010-05-17
ES2347134T3 (es) 2010-10-26
WO2002008295A1 (fr) 2002-01-31
NO20030296D0 (no) 2003-01-20
UA74836C2 (en) 2006-02-15
NZ524028A (en) 2004-12-24
CA2416673A1 (fr) 2002-01-31
PL365561A1 (en) 2005-01-10
OA12340A (fr) 2006-05-15
AP1703A (en) 2007-02-26
BR0112612B1 (pt) 2011-07-12
EA005995B1 (ru) 2005-08-25
AU2001277602B2 (en) 2007-07-19
AU7760201A (en) 2002-02-05
YU2903A (sh) 2006-03-03
EP1307491A1 (fr) 2003-05-07
DE60142340D1 (de) 2010-07-22
ES2347134T5 (es) 2014-06-24
AR029865A1 (es) 2003-07-16
HUP0300755A2 (hu) 2003-12-29
JP5279160B2 (ja) 2013-09-04
KR100853585B1 (ko) 2008-08-21
MA26928A1 (fr) 2004-12-20
PL202471B1 (pl) 2009-06-30
HUP0300755A3 (en) 2004-03-01
BR0112612A (pt) 2003-07-29
DZ3411A1 (fr) 2002-01-31
CN1447820A (zh) 2003-10-08
AP2003002744A0 (en) 2003-03-31
ECSP034442A (es) 2003-03-10
JP2004504451A (ja) 2004-02-12
TWI307278B (en) 2009-03-11
HRP20030019A2 (en) 2005-10-31
KR20030040364A (ko) 2003-05-22
EP1307491B1 (fr) 2010-06-09
EP1307491B2 (fr) 2014-05-07
PT1307491E (pt) 2010-09-10
EA200300178A1 (ru) 2003-06-26
ZA200300898B (en) 2004-04-30
CN1230449C (zh) 2005-12-07
FR2811992B1 (fr) 2003-07-04
CY1110774T1 (el) 2015-06-10
FR2811992A1 (fr) 2002-01-25
ATE470679T1 (de) 2010-06-15
DK1307491T3 (da) 2010-10-11
MXPA03000579A (es) 2003-06-06
CL2004001154A1 (es) 2005-05-27
SI1307491T1 (sl) 2010-10-29
IL153922A0 (en) 2003-07-31

Similar Documents

Publication Publication Date Title
NO20030296L (no) Heparinavledede polysakkaridblandinger, deres fremstilling samt farmasöytiske preparater inneholdende blandingene
DK1263720T3 (da) Azetidinderivater, fremstilling deraf samt farmaceutiske sammensætninger, der indeholder samme
NO20032187D0 (no) Heterocyklylalkylpiperidinderivater, deres fremstilling samt preparater inneholdende forbindelsene
NO324250B1 (no) Diazabicykliske forbindelser, farmasoytiske sammensetninger omfattende disse samt deres anvendelse
NO20010013D0 (no) Svovelsubstituerte sulfonylaminokarboksylsyre N-arylamider, deres fremstilling og anvendelse samt farmasöytiske preparater inneholdende forbindelsene
NO20011216L (no) Azetidinderivater, deres fremstilling og medikamenter inneholdende forbindelsene
NO20032438D0 (no) Orto- og metasubstituerte bis-arylforbindelser, deres fremstilling og anvendelse samt farmasöytiske preparater inneholdende forbindelsene
NO20025450L (no) Ny farmasöytisk sammensetning
ITTO20010005A0 (it) Formulazione farmaceutica.
DK1112251T3 (da) Azetidinderivater, deres fremstilling og medikamenter indeholdende disse derivater
NO20005146L (no) Tienylazolylalkoksyetanaminer, deres fremstilling og deres anvendelse som medikamenter
DK1095025T3 (da) Benzimidazoler, deres fremstilling og deres anvendelse som lægemidler
NO20023400L (no) Nye forbindelser med hypolidemisk og hypokolesteremisk virkning, deres fremstilling samt preparater inneholdendeforbindelsene
NO20022021D0 (no) Indeno-, nafto- og benzocyklohepta-dihydrotiazolderivater, fremstilling av de samme og deres anvendelse somanoreksilegemidler
HK1094806A1 (en) Heparin-derived oligosaccharide mixtures, preparation thereof and pharmaceutical compositions containing said mixtures
NO20016247L (no) Streptograminderivater, deres fremstilling samt preparater inneholdende derivatene
NO20022022L (no) N-guanidinoalkylamider, deres fremstilling, deres anvendelse og farmasöytiske preparater omfattende disse
DK1118610T3 (da) Benzensulfonamid-derivater, fremgangsmåde til fremstilling heraf samt farmaceutiske sammensætninger indeholdende derivaterne
NO20003661L (no) Nye pentasakkarider, fremgangsmÕter for deres fremstilling og farmasøytiske preparater inneholdende de samme
NO20024590L (no) Farmasöytiske preparater inneholdende oligosakkarider, de nye oligosakkarider samt deres fremstilling
NO20014692D0 (no) 3-amidinobenzensulfonamidderivater, medisinske sammensetninger inneholdende slike samt intermediater vedfremstillingen derav
IL154986A0 (en) Triazolo-epothilone derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof
DK1176148T3 (da) Benzothiadiazinforbindelser, fremgangsmåde til fremstilling heraf samt farmaceutiske sammensætninger indeholdende disse
NO20020404L (no) Streptograminderivater, deres fremstilling samt preparater inneholdende derivatene
NO20004075D0 (no) Substituerte pyrimidin-2-yloksy-karboksylsyrederivater, fremstilling av disse og deres anvendelse som endotelin- antagonister

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application